Eubiotics Market Estimates and Forecast From 2014 to 2025 by Dhanashree

Eubiotics Market Revenue Will Exceed $9.4 Billion By 2025 With Growth Rate Of CAGR: 8.2%

â&#x20AC;&#x153;Growing meat consumption coupled with rising awareness regarding meat quality is expected to drive global eubiotics market growth.â&#x20AC;?

The global Eubiotics Market is expected to reach USD 9.4 billion by 2025, according to a new report by Grand View Research, Inc. Growing meat consumption coupled with rising awareness regarding meat quality is expected to drive global eubiotics market growth. Access Full Research Report on Global Eubiotics Market: http://www.grandviewresearch.com/industry-analysis/eubiotics-market Eubiotics influence the gut microflora and confer health benefits on the host. They maintain a correct balance of the microbial activity in the gastrointestinal tract of animals. This results in benefits such as enhanced nutrient absorption, better immunity and increase in overall performance. Such advantages are expected to drive the market growth over the forecast period.

Probiotics emerged as the largest product segment in 2016 and was valued at USD 2.5 billion in 2016. Broad product portfolio, rising awareness and efficacy in animal feed usage are the major attributed reasons for this scenario Gut health dominated the application segment in 2016 and is expected to grow at an anticipated CAGR of 8.2% from 2017 to 2025. Eubiotics efficiency in treating gut related disorders and search for viable alternative to antibiotics are expected to drive market growth. Immunity is expected to observe the fastest growth among applications. Fodder and water shortage, decreasing grazing lands has put pressure on livestock farmers to optimize feed utilization. Eubiotics cater to this demand by enhancing feed utilization, and increasing yield in comparatively less feed. Such trends are expected to fuel market growth over the next eight years. Further key findings from the study suggest: 

The global eubiotics market worth is expected to be 9.4 billion and is expected to grow at a CAGR of 8.2% from 2017 to 2025



Solid form dominated the form segment and was valued at USD 2.9 billion in 2016. Liquid form is expected to grow at an anticipated CAGR of 8.0% over the next eight years



The U.S. market worth for eubiotics used in poultry end use was USD 264.6 million in 2016. Rising demand for poultry meat and eggs, demand for high quality meat and concerns over antibiotics have resulted in an increased preference for usage in poultry end use.



Asia Pacific is expected to witness the highest growth rate over the next eight years. Strong demand from countries such as China and India, growing meat consumption in the region and rising concerns over antibiotics usage is expected to fuel market growth



Companies are focusing on developing regions such as Asia Pacific to increase market share. Key industry participants include Calpis, DSM, Novus, Lesaffre Group, Lallemand Inc., and E.I. Du Pont De Nemours and Company.

Grand View Research has segmented the global Eubiotics Market on the basis of product, form, application, end use and region: Read Our Blogs on Reports from this category By Grand View Research: http://www.grandviewresearch.com/blogs/bulk-chemicals Table of Content of Global Eubiotics Market Research Report: Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions 1.3. List of Data Sources Chapter 2. Executive Summary 2.1. Market Snapshot Chapter 3. Eubiotics Market Variables, Trends & Scope 3.1. Market segmentation 3.2. Market size and growth prospects, 2014 - 2025 3.3. Value chain analysis 3.4. Regulatory Framework 3.5. Market dynamics 3.5.1. Market driver analysis 3.5.2. Market restraint analysis 3.6. Key opportunities prioritized 3.7. Industry analysis - Porter's 3.8. PESTEL analysis, 2016 Chapter 4. Eubiotics Market: Product Outlook 4.1. Eubiotics market share by product, 2016 & 2025 (USD Million) 4.2. Probiotics 4.2.1. Market estimates and forecast, 2014 - 2025 (USD Million) 4.2.2. Market estimates and forecast by region, 2014 - 2025 (USD Million)

4.3. Prebiotics 4.3.1. Market estimates and forecast, 2014 - 2025 (USD Million) 4.3.2. Market estimates and forecast by region, 2014 - 2025 (USD Million) 4.4. Organic Acids 4.4.1. Market estimates and forecast, 2014 - 2025 (USD Million) 4.4.2. Market estimates and forecast by region, 2014 - 2025 (USD Million) 4.5. Essential Oils 4.5.1. Market estimates and forecast, 2014 - 2025 (USD Million) 4.5.2. Market estimates and forecast by region, 2014 - 2025 (USD Million) Chapter 5. Eubiotics Market: Form Outlook 5.1. Eubiotics market share by form, 2016 & 2025(USD Million) 5.2. Liquid Form 5.2.1. Market estimates and forecast, 2014 - 2025 (USD Million) 5.2.2. Market estimates and forecast by region, 2014 - 2025 (USD Million) 5.3. Solid Form 5.3.1. Market estimates and forecast, 2014 - 2025 (USD Million) 5.3.2. Market estimates and forecast by region, 2014 - 2025 (USD Million) Chapter 6. Eubiotics Market: Application Outlook 6.1. Eubiotics market share by application, 2016 & 2025 (USD Million) 6.2. Gut health 6.2.1. Market estimates and forecast, 2014 - 2025 (USD Million) 6.2.2. Market estimates and forecast by region, 2014 - 2025 (USD Million) 6.3. Immunity 6.3.1. Market estimates and forecast, 2014 - 2025 (USD Million) 6.3.2. Market estimates and forecast by region, 2014 - 2025 (USD Million) 6.4. Yield 6.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)

6.4.2. Market estimates and forecast by region, 2014 - 2025 (USD Million) 6.5. Others 6.5.1. Market estimates and forecast, 2014 - 2025 (USD Million) 6.5.2. Market estimates and forecast by region, 2014 - 2025 (USD Million) Chapter 7. Eubiotics Market: End-use Outlook 7.1. Eubiotics market share by application, 2016 & 2025 (USD Million) 7.2. Cattle Feed 7.2.1. Market estimates and forecast, 2014 - 2025 (USD Million) 7.2.2. Market estimates and forecast by region, 2014 - 2025 (USD Million) 7.2.3. Dairy 7.2.3.1. Market estimates and forecast, 2014 - 2025 (USD Million) 7.2.3.2. Market estimates and forecast by region, 2014 - 2025 (USD Million) 7.2.4. Meat 7.2.4.1. Market estimates and forecast, 2014 - 2025 (USD Million) 7.2.4.2. Market estimates and forecast by region, 2014 - 2025 (USD Million) 7.3. Poultry 7.3.1. Market estimates and forecast, 2014 - 2025 (USD Million) 7.3.2. Market estimates and forecast by region, 2014 - 2025 (USD Million) 7.4. Swine 7.4.1. Market estimates and forecast, 2014 - 2025 (USD Million) 7.4.2. Market estimates and forecast by region, 2014 - 2025 (USD Million) 7.5. Aquatic 7.5.1. Market estimates and forecast, 2014 - 2025 (USD Million) 7.5.2. Market estimates and forecast by region, 2014 - 2025 (USD Million) 7.6. Others

7.6.1. Market estimates and forecast, 2014 - 2025 (USD Million) 7.6.2. Market estimates and forecast by region, 2014 - 2025 (USD Million) Chapter 8. Eubiotics Market: Regional Outlook 8.1. Eubiotics market share by region, 2016 & 2025 (USD Million) 8.2. North America 8.2.1. Market estimates and forecast, 2014 - 2025 (USD Million) 8.2.2. Market estimates and forecast by product, 2014 - 2025 (USD Million) 8.2.3. Market estimates and forecast by form, 2014 - 2025 (USD Million) 8.2.4. Market estimates and forecast by application, 2014 - 2025 (USD Million) 8.2.5. Market estimates and forecast by end use, 2014 - 2025 (USD Million) 8.2.6. U.S. 8.2.6.1. Market estimates and forecast, 2014 - 2025 (USD Million) 8.2.6.2. Market estimates and forecast by product, 2014 - 2025 (USD Million) 8.2.6.3. Market estimates and forecast by form, 2014 - 2025 (USD Million) 8.2.6.4. Market estimates and forecast by application, 2014 - 2025 (USD Million) 8.2.6.5. Market estimates and forecast by end use, 2014 - 2025 (USD Million) 8.3. Europe 8.3.1. Market estimates and forecast, 2014 - 2025 (USD Million) 8.3.2. Market estimates and forecast by product, 2014 - 2025 (USD Million)

8.3.3. Market estimates and forecast by form, 2014 - 2025 (USD Million) 8.3.4. Market estimates and forecast by application, 2014 - 2025 (USD Million) 8.3.5. Market estimates and forecast by end use, 2014 - 2025 (USD Million) 8.3.6. Germany 8.3.6.1. Market estimates and forecast, 2014 - 2025 (USD Million) 8.3.6.2. Market estimates and forecast by product, 2014 - 2025 (USD Million) 8.3.6.3. Market estimates and forecast by form, 2014 - 2025 (USD Million) 8.3.6.4. Market estimates and forecast by application, 2014 - 2025 (USD Million) 8.3.6.5. Market estimates and forecast by end use, 2014 - 2025 (USD Million) 8.3.7. UK 8.3.7.1. Market estimates and forecast, 2014 - 2025 (USD Million) 8.3.7.2. Market estimates and forecast by product, 2014 - 2025 (USD Million) 8.3.7.3. Market estimates and forecast by form, 2014 - 2025 (USD Million) 8.3.7.4. Market estimates and forecast by application, 2014 - 2025 (USD Million) 8.3.7.5. Market estimates and forecast by end use, 2014 - 2025 (USD Million) 8.3.8. France 8.3.8.1. Market estimates and forecast, 2014 - 2025 (USD Million)

8.3.8.2. Market estimates and forecast by product, 2014 - 2025 (USD Million) 8.3.8.3. Market estimates and forecast by form, 2014 - 2025 (USD Million) 8.3.8.4. Market estimates and forecast by application, 2014 - 2025 (USD Million) 8.3.8.5. Market estimates and forecast by end use, 2014 - 2025 (USD Million) 8.3.9. Spain 8.3.9.1. Market estimates and forecast, 2014 - 2025 (USD Million) 8.3.9.2. Market estimates and forecast by product, 2014 - 2025 (USD Million) 8.3.9.3. Market estimates and forecast by form, 2014 - 2025 (USD Million) 8.3.9.4. Market estimates and forecast by application, 2014 - 2025 (USD Million) 8.3.9.5. Market estimates and forecast by end use, 2014 - 2025 (USD Million) 8.4. Asia Pacific 8.4.1. Market estimates and forecast, 2014 - 2025 (USD Million) 8.4.2. Market estimates and forecast by product, 2014 - 2025 (USD Million) 8.4.3. Market estimates and forecast by form, 2014 - 2025 (USD Million) 8.4.4. Market estimates and forecast by application, 2014 - 2025 (USD Million) 8.4.5. Market estimates and forecast by end use, 2014 - 2025 (USD Million)

8.4.6. China 8.4.6.1. Market estimates and forecast, 2014 - 2025 (USD Million) 8.4.6.2. Market estimates and forecast by product, 2014 - 2025 (USD Million) 8.4.6.3. Market estimates and forecast by form, 2014 - 2025 (USD Million) 8.4.6.4. Market estimates and forecast by application, 2014 - 2025 (USD Million) 8.4.6.5. Market estimates and forecast by end use, 2014 - 2025 (USD Million) 8.4.7. India 8.4.7.1. Market estimates and forecast, 2014 - 2025 (USD Million) 8.4.7.2. Market estimates and forecast by product, 2014 - 2025 (USD Million) 8.4.7.3. Market estimates and forecast by form, 2014 - 2025 (USD Million) 8.4.7.4. Market estimates and forecast by application, 2014 - 2025 (USD Million) 8.4.7.5. Market estimates and forecast by end use, 2014 - 2025 (USD Million) 8.4.8. Japan 8.4.8.1. Market estimates and forecast, 2014 - 2025 (USD Million) 8.4.8.2. Market estimates and forecast by product, 2014 - 2025 (USD Million) 8.4.8.3. Market estimates and forecast by form, 2014 - 2025 (USD Million) 8.4.8.4. Market estimates and forecast by application, 2014 - 2025

(USD Million) 8.4.8.5. Market estimates and forecast by end use, 2014 - 2025 (USD Million) 8.5. Central & South America 8.5.1. Market estimates and forecast, 2014 - 2025 (USD Million) 8.5.2. Market estimates and forecast by product, 2014 - 2025 (USD Million) 8.5.3. Market estimates and forecast by form, 2014 - 2025 (USD Million) 8.5.4. Market estimates and forecast by application, 2014 - 2025 (USD Million) 8.5.5. Market estimates and forecast by end use, 2014 - 2025 (USD Million) 8.6. Middle East & Africa 8.6.1. Market estimates and forecast, 2014 - 2025 (USD Million) 8.6.2. Market estimates and forecast by product, 2014 - 2025 (USD Million) 8.6.3. Market estimates and forecast by form, 2014 - 2025 (USD Million) 8.6.4. Market estimates and forecast by application, 2014 - 2025 (USD Million) 8.6.5. Market estimates and forecast by end use, 2014 - 2025 (USD Million) Chapter 9. Competitive Landscape 9.1. Company heat map analysis 9.2. Vendor landscape 9.3. Strategy framework 9.4. Competitive environment Chapter 10. Company Profiles

10.1. DSM 10.1.1. Company Overview 10.1.2. Financial Performance 10.1.3. Industries and services catered 10.1.4. Product Benchmarking 10.1.5. Strategic Initiatives 10.2. MSP Eubiotics 10.2.1. Company Overview 10.2.2. Financial Performance 10.2.3. Industries and services catered 10.2.4. Product Benchmarking 10.2.5. Strategic Initiatives 10.3. Greenvet 10.3.1. Company Overview 10.3.2. Financial Performance 10.3.3. Industries and services catered 10.3.4. Product Benchmarking 10.3.5. Strategic Initiatives 10.4. E.I. Du Pont De Nemours and Company 10.4.1. Company Overview 10.4.2. Financial Performance 10.4.3. Industries and services catered 10.4.4. Product Benchmarking 10.4.5. Strategic Initiatives 10.5. Novus 10.5.1. Company Overview 10.5.2. Financial Performance

10.5.3. Industries and services catered 10.5.4. Product Benchmarking 10.5.5. Strategic Initiatives 10.6. Calpis 10.6.1. Company Overview 10.6.2. Financial Performance 10.6.3. Industries and services catered 10.6.4. Product Benchmarking 10.6.5. Strategic Initiatives 10.7. Nebraska Cultures Inc. 10.7.1. Company Overview 10.7.2. Financial Performance 10.7.3. Industries and services catered 10.7.4. Product Benchmarking 10.7.5. Strategic Initiatives 10.8. Lallemand Inc. 10.8.1. Company Overview 10.8.2. Financial Performance 10.8.3. Industries and services catered 10.8.4. Product Benchmarking 10.8.5. Strategic Initiatives 10.9. Advanced BioNutrition Corp 10.9.1. Company Overview 10.9.2. Financial Performance 10.9.3. Industries and services catered 10.9.4. Product Benchmarking 10.9.5. Strategic Initiatives

10.10. Beneo Group 10.10.1. Company Overview 10.10.2. Financial Performance 10.10.3. Industries and services catered 10.10.4. Product Benchmarking 10.10.5. Strategic Initiatives 10.11. Behn Meyer 10.11.1. Company Overview 10.11.2. Financial Performance 10.11.3. Industries and services catered 10.11.4. Product Benchmarking 10.11.5. Strategic Initiatives 10.12. Kemin Industries Inc. 10.12.1. Company Overview 10.12.2. Financial Performance 10.12.3. Industries and services catered 10.12.4. Product Benchmarking 10.12.5. Strategic Initiatives 10.13. Lesaffre Group 10.13.1. Company Overview 10.13.2. Financial Performance 10.13.3. Industries and services catered 10.13.4. Product Benchmarking 10.13.5. Strategic Initiatives 10.14. Novozymes 10.14.1. Company Overview 10.14.2. Financial Performance

10.14.3. Industries and services catered 10.14.4. Product Benchmarking 10.14.5. Strategic Initiatives About Grand View Research, Inc.:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com